PDX Programs for Clinical Advancement of Oncology Agents

Logo
Presented by

Neal Goodwin, PhD, Vice President of Research Development

About this talk

The Champions TumorGraft platform is being used for conducting high throughput translational medicine trials across a multitude of patient tumor models, including AML and ALL. This informative webinar will specifically cover introduction to the PDX algorithm, overview of the Champions Oncology PDX tumor bank, overview of the Champions Oncology co-clinical program, AML modeling, CD34+ HSC-derived humanized PDX models for immunotherapy testing.

Related topics:

More from this channel

Upcoming talks (0)
On-demand talks (50)
Subscribers (2622)
Champions Oncology delivers innovative solutions to oncology drug development, accelerating the journey from the research bench to the clinic – decreasing timelines, lowering costs, and ultimately saving patient lives. Learn more about Champions Oncology's capabilities, our service platforms and educational topics affecting our industry on our Webinar Channel.